NCT06409143

High-definition Transcranial Electrical Stimulation for Upper Extremity Rehabilitation

Neural Mechanisms and Augmented Efficacy of High-definition Transcranial Electrical Stimulation on Upper-extremity Function in Patients With Subacute Stroke
National Taiwan University Hospital·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
HD-tES
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
National Taiwan University Hospital
Location
New Taipei City,Taipei,Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Nov 30, 2026
Enrollment
152 participants
Primary outcome

Pre- and 3-month change in motor function of the upper limbs assessed by Fugl-Meyer Assessment of Upper Extremity (FMA-UE),Pre- and 3-month change in motor function of the upper limbs assessed by Action Research Arm Test (ARAT)

Summary

Upper limb hemiparesis is the most common sequelae in patients, severely impacting their
 independence and quality of life. Transcranial electrical stimulation (tCES) is a
 non-invasive and safe treatment, which uses a low direct current or alternating current to
 change the excitability of the cerebral cortex. It can induces long-term potentiation-like or
 long-term depression-like effects, thereby modulating the cortical excitability. In recent
 years, researchers have developed high-definition (HD) devices, which integrate high
 definition ring electrode configurations and incorporate direct current with theta burst
 stimulation waveforms. Diverging from traditional transcranial direct current stimulation
 (tDCS), which applies weak currents (0.5-2 mA) through two large sponge electrodes (25~35
 cm^2) externally to the scalp for widespread non-specific cortical stimulation, HD-tES
 employs an array of small-area electrodes (1 cm^2) to control current distribution over
 localized cortical regions, thereby enhancing spatial accuracy. However, there is a lack of
 studies validating the optimal waveform for HD-tES, as well as clinical evidence in subacute
 stroke populations. The optimal unilateral versus bilateral stimulation modes and their
 neurological mechanisms for stroke rehabilitation also remain uncertain.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06409143
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06409143 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 152 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.